����������

The AHA Friday urged the National Academies of Sciences, Engineering and Medicine to adopt a unified set of guidelines to account for the variables associated with all issues of the eventual allocation of COVID-19 vaccine allocation.

In an effort to ensure the process remains equitable, AHA stressed the importance of a singular message to the public and other stakeholders.

“The country has been confused by the multiple and sometimes conflicting information on testing, infection prevention, return-to-work and school and many other decision points as we move through this pandemic,” AHA wrote. “We recognize that science is evolving, but in this extremely important consideration of achieving immunity, we cannot further the uncertainty of individuals, providers or public health officials.”

Read AHA’s full comments, which also address vaccine hesitancy, the potential for multiple available vaccines, comorbidity considerations and public- and private-sector decisions and policies.